Hindalco announces allotment of 70,000 NCDs of ₹1,00,000 each

Hindalco announces allotment of 70,000 NCDs of ₹1,00,000 each

The debenture issue is of ₹1,00,000 each aggregating to ₹700 Crores, on a private placement basis

FPJ Web DeskUpdated: Wednesday, January 18, 2023, 11:12 AM IST
article-image
Hindalco announces allotment of 70,000 NCDs of ₹1,00,000 each | Image credit: Hindalco (Representative)

Hindalco Industries Limited, a subsidiary of the Aditya Birla Group, announced that the Capital Raising Committee of the Board of Directors of the Company has today approved allotment of 70,000 – 7.60% p.a., rated, listed, unsecured, redeemable, non-convertible debentures, via an exchange filing.

The debenture issue is of ₹1,00,000 each aggregating to ₹700 Crores, on a private placement basis.

The announcement is as per disclosure in terms of Regulation 30 of Listing Regulations is enclosed. [Annexure A].

The said NCDs have been rated as AA+ (Stable) by CARE Ratings Limited.

RECENT STORIES

FPIs Pull Out ₹11,820 Crore In Early December, Rupee Slide & Global Uncertainty Shake Indian...

FPIs Pull Out ₹11,820 Crore In Early December, Rupee Slide & Global Uncertainty Shake Indian...

Wakefit Raises ₹186 Crore Ahead Of ₹1,289-Crore IPO As Steadview, WhiteOak And Capital 2B Buy...

Wakefit Raises ₹186 Crore Ahead Of ₹1,289-Crore IPO As Steadview, WhiteOak And Capital 2B Buy...

Top Companies Add Massive Value In A Weak Market, TCS & Infosys Lead The Weekly Surge

Top Companies Add Massive Value In A Weak Market, TCS & Infosys Lead The Weekly Surge

SoftBank-Backed AceVector Files Updated IPO Papers With Sebi; Plans ₹300-Crore Fresh Issue And...

SoftBank-Backed AceVector Files Updated IPO Papers With Sebi; Plans ₹300-Crore Fresh Issue And...

Biocon’s Bold Bet On Biologics, A Restructuring Move That Could Redefine Its Future & Move The...

Biocon’s Bold Bet On Biologics, A Restructuring Move That Could Redefine Its Future & Move The...